To be fair I'd take that list and expand it to include the big pharmaceutical companies (see the new Alzheimers drug scandal at the FDA, billions spent on next

To be fair I'd take that list and expand it to include the big pharmaceutical companies (see the new Alzheimers drug scandal at the FDA, billions spent on next generation statins that proved ineffective by confusing correlation and causation, etc), to include doctors and surgeons and various surgical practices or novel medical treatments (billions spent on full Meniscectomies that just lead to arthritis after years, pointless heart stints, etc). True many startups in health are trying scammy payment models, but hospital bills often aren't much better unfortunately. Personally my life has been positively improved by 23andme when they could still list health research, or by "zany" microbiome/probiotics startups years before the medical establishment caught up. Obviously these fields should be regulated, but properly so without just providing an excuse for regulatory capture for existing players. 0: https://www.nytimes.com/2021/07/19/health/alzheimers-drug-aduhelm-fda.html https://www.nytimes.com/2021/07/19/health/alzheimers-drug-ad... 1: https://www.crossfit.com/health/the-great-statin-scam-time-to-clean-up-the-mess https://www.crossfit.com/health/the-great-statin-scam-time-t... 2: https://www.vox.com/the-big-idea/2017/12/28/16823266/medical-treatments-evidence-based-expensive-cost-stents https://www.vox.com/the-big-idea/2017/12/28/16823266/medical... 3: https://www.theatlantic.com/health/archive/2017/02/when-evidence-says-no-but-doctors-say-yes/517368/ https://www.theatlantic.com/health/archive/2017/02/when-evid...